289 related articles for article (PubMed ID: 31178725)
1. Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis.
Liu X; Shan X; Chen H; Li Z; Zhao P; Zhang C; Guo W; Xu M; Lu R
Front Pharmacol; 2019; 10():538. PubMed ID: 31178725
[TBL] [Abstract][Full Text] [Related]
2. Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis.
Chen HH; Zhao P; Zhao WX; Tian J; Guo W; Xu M; Zhang C; Lu R
Am J Transl Res; 2017; 9(9):4250-4260. PubMed ID: 28979698
[TBL] [Abstract][Full Text] [Related]
3. Buyanghuanwu Decoction alleviated pressure overload induced cardiac remodeling by suppressing Tgf-β/Smads and MAPKs signaling activated fibrosis.
Chen H; Song H; Liu X; Tian J; Tang W; Cao T; Zhao P; Zhang C; Guo W; Xu M; Lu R
Biomed Pharmacother; 2017 Nov; 95():461-468. PubMed ID: 28865366
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
Chen R; Feng Y; Wu J; Song Y; Li H; Shen Q; Li D; Zhang J; Lu Z; Xiao H; Zhang Y
Br J Pharmacol; 2018 Apr; 175(8):1217-1229. PubMed ID: 28230250
[TBL] [Abstract][Full Text] [Related]
5. Asenapine maleate inhibits angiotensin II-induced proliferation and activation of cardiac fibroblasts via the ROS/TGFβ1/MAPK signaling pathway.
Wu HH; Meng TT; Chen JM; Meng FL; Wang SY; Liu RH; Chen JN; Ning B; Li Y; Su GH
Biochem Biophys Res Commun; 2021 May; 553():172-179. PubMed ID: 33773140
[TBL] [Abstract][Full Text] [Related]
6. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
8. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
[TBL] [Abstract][Full Text] [Related]
10. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
11. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-TGF-beta 1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages.
Uhal BD; Kim JK; Li X; Molina-Molina M
Curr Pharm Des; 2007; 13(12):1247-56. PubMed ID: 17504233
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3.
Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J
Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251
[TBL] [Abstract][Full Text] [Related]
15. [AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
Xiao H; Piao CS; Chen RF; Zhang YY
Sheng Li Xue Bao; 2017 Apr; 69(2):123-128. PubMed ID: 28435970
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of Smads/miR-675/TGFβR1 axis modulating the proliferation and remodeling of mouse cardiac fibroblasts.
Wang L; Jiang P; He Y; Hu H; Guo Y; Liu X; Qiu H; Ma Q; Ouyang F
J Cell Physiol; 2019 Nov; 234(11):20275-20285. PubMed ID: 30953355
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FAF inhibits fibrosis induced by angiotensinogen II via the TGFβ1-P-Smad2/3 signalling by targeting FGF9 in cardiac fibroblasts.
Sun J; Wang Z; Shi H; Gu L; Wang S; Wang H; Li Y; Wei T; Wang Q; Wang L
Biochem Biophys Res Commun; 2020 Jan; 521(3):814-820. PubMed ID: 31708099
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
[TBL] [Abstract][Full Text] [Related]
20. CTRP15 derived from cardiac myocytes attenuates TGFβ1-induced fibrotic response in cardiac fibroblasts.
Zhao Q; Zhang CL; Xiang RL; Wu LL; Li L
Cardiovasc Drugs Ther; 2020 Oct; 34(5):591-604. PubMed ID: 32424654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
